ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives $24.00 Average Price Target from Analysts
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by ...
ACADIA Pharmaceuticals (ACAD) Projected to Post Earnings on Wednesday
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce ...
Acadia Pharmaceuticals: Good Progress Means I'm Reversing My 'Sell' Call To 'Buy'
Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...
Acadia Pharmaceuticals initiated with a Hold at Deutsche Bank
Deutsche Bank initiated coverage of Acadia Pharmaceuticals (ACAD) with a Hold rating and $22 price target Maximize Your Portfolio with Data ...
Morgan Stanley Remains a Hold on ACADIA Pharmaceuticals (ACAD)
Morgan Stanley analyst Jeffrey Hung maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price target of ...